What is King Pharmaceuticals's FX effect on cash?

King Pharmaceuticals (KG) reported FX effect on cash of -$548K in Q1 2026.

What does FX effect on cash mean?

The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.

King Pharmaceuticals KG FX Effect on Cash

FX Effect on Cash at other companies

Arch Capital GroupACGL

-$8M-150%

Everest GroupEG

$28M+256%

KKR & Co.KKR

-$68.32M-442%

Reinsurance Group of AmericaRGA

-$17M-171%

Verisk Analytics, Inc.VRSK

-$1.8M-357%

Tiptree Inc.TIPT

——

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's fx effect on cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's FX effect on cash?: King Pharmaceuticals (KG) reported FX effect on cash of -$548K in Q1 2026.
What does FX effect on cash mean?: The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.